Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Laura Sánchez-de Prada, Iván Sanz-Muñoz, Raúl Ortiz de Lejarazu, José María Eiros, Adolfo García-Sastre & Teresa Aydillo. (2022) Immunodominance hierarchy after seasonal influenza vaccination. Emerging Microbes & Infections 11:1, pages 2670-2679.
Read now
Read now
Orli Even-Or, Shani Avniel-Polak, Yechezkel Barenholz & Gabriel Nussbaum. (2020) The cationic liposome CCS/C adjuvant induces immunity to influenza independently of the adaptor protein MyD88. Human Vaccines & Immunotherapeutics 16:12, pages 3146-3154.
Read now
Read now
Adam Kenneth Wheatley & Stephen John Kent. (2015) Prospects for antibody-based universal influenza vaccines in the context of widespread pre-existing immunity. Expert Review of Vaccines 14:9, pages 1227-1239.
Read now
Read now
Leah F Moriarty & Saad B Omer. (2014) Infants and the seasonal influenza vaccine. Human Vaccines & Immunotherapeutics 10:9, pages 2721-2728.
Read now
Read now
Articles from other publishers (26)
Manish M. Patel, Lisa A. Grohskopf, Suryaprakash Sambhara, Jessica A. Belser, Jacqueline M. Katz & Alicia M. Fry. 2023. Plotkin's Vaccines. Plotkin's Vaccines
514
551.e31
.
Beata Gromadzka, Milena Chraniuk, Lilit Hovhannisyan, Karolina Uranowska, Bogusław Szewczyk, Magdalena Narajczyk & Mirosława Panasiuk. (2022) Characterization of Immune Response towards Generation of Universal Anti-HA-Stalk Antibodies after Immunization of Broiler Hens with Triple H5N1/NA-HA-M1 VLPs. Viruses 14:4, pages 730.
Crossref
Crossref
M.R. Schleiss. 2022. Encyclopedia of Infection and Immunity. Encyclopedia of Infection and Immunity
545
555
.
E. Y. Boravleva, A. V. Lunitsin, A. P. Kaplun, N. V. Bykova, I. V. Krasilnikov & A. S. Gambaryan. (2020) Immune Response and Protective Efficacy of Inactivated and Live Influenza Vaccines Against Homologous and Heterosubtypic Challenge. Biochemistry (Moscow) 85:5, pages 553-566.
Crossref
Crossref
Cynthia Calzas & Christophe Chevalier. (2019) Innovative Mucosal Vaccine Formulations Against Influenza A Virus Infections. Frontiers in Immunology 10.
Crossref
Crossref
Daniel Weibel, Miriam Sturkenboom, Steven Black, Maria de Ridder, Caitlin Dodd, Jan Bonhoeffer, Ann Vanrolleghem, Nicoline van der Maas, Gert Jan Lammers, Sebastiaan Overeem, Angela Gentile, Norberto Giglio, Vanesa Castellano, Jeffrey C. Kwong, Brian J. Murray, Karen Cauch-Dudek, Diana Juhasz, Michael Campitelli, Alexandre N. Datta, Ulf Kallweit, Wan-Ting Huang, Yu-Shu Huang, Chung-Yao Hsu, Hsi-Chung Chen, Maria Giner-Soriano, Rosa Morros, Carles Gaig, Ester Tió, Silvia Perez-Vilar, Javier Diez-Domingo, Francisco Javier Puertas, Lawrence W. Svenson, Salaheddin M. Mahmud, Bruce Carleton, Monika Naus, Lisen Arnheim-Dahlström, Lars Pedersen, Frank DeStefano & Tom T. Shimabukuro. (2018) Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines – Multi-country assessment. Vaccine 36:41, pages 6202-6211.
Crossref
Crossref
Sofia E. Magnusson, Arwen F. Altenburg, Karin Lövgren Bengtsson, Fons Bosman, Rory D. de Vries, Guus F. Rimmelzwaan & Linda Stertman. (2018) Matrix-M™ adjuvant enhances immunogenicity of both protein- and modified vaccinia virus Ankara-based influenza vaccines in mice. Immunologic Research 66:2, pages 224-233.
Crossref
Crossref
Joseph S. Bresee, Alicia M. Fry, Suryaprakash Sambhara & Nancy J. Cox. 2018. Plotkin's Vaccines. Plotkin's Vaccines
456
488.e21
.
Thomas Ebensen, Jennifer Debarry, Gabriel K. Pedersen, Paulina Blazejewska, Sebastian Weissmann, Kai Schulze, Kenneth C. McCullough, Rebecca J. Cox & Carlos A. Guzmán. (2017) Mucosal Administration of Cycle-Di-Nucleotide-Adjuvanted Virosomes Efficiently Induces Protection against Influenza H5N1 in Mice. Frontiers in Immunology 8.
Crossref
Crossref
Sina Soleimani, Shahla Shahsavandi & Omid Maddadgar. (2017) Improvement influenza HA2 DNA vaccine cellular and humoral immune responses with Mx bio adjuvant. Biologicals 46, pages 6-10.
Crossref
Crossref
Erik A. Karlsson, Tomer Hertz, Cydney Johnson, Andrew Mehle, Florian Krammer & Stacey Schultz-Cherry. (2016) Obesity Outweighs Protection Conferred by Adjuvanted Influenza Vaccination. mBio 7:4.
Crossref
Crossref
Jerry P. Weir & Marion F. Gruber. (2016) An overview of the regulation of influenza vaccines in the United States. Influenza and Other Respiratory Viruses 10:5, pages 354-360.
Crossref
Crossref
F. Antón, M.J. Richart, S. Serrano, A.M. Martínez & D.F. Pruteanu. (2016) Estrategias para mejorar la cobertura de la vacunación antigripal en Atención Primaria. SEMERGEN - Medicina de Familia 42:3, pages 147-151.
Crossref
Crossref
Shin-ichi Tamura, Akira Ainai, Tadaki Suzuki, Takeshi Kurata & Hideki Hasegawa. (2016) Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?. Japanese Journal of Infectious Diseases 69:3, pages 165-179.
Crossref
Crossref
Sina Soleimani, Omid Madadgar, Shahla Shahsavandi, Homayoon Mahravani & Mohsen Lotfi. (2015) In Silico Analysis of HA2/Mx Chimera Peptide for Developing an Adjuvanted Vaccine to Induce Immune Responses Against Influenza Viruses. Advanced Pharmaceutical Bulletin 5:Suppl 1, pages 629-636.
Crossref
Crossref
Arun Kumar & Shakti Singh. (2015) Editorial: Influenza Virus Vaccines and Immunotherapies. Frontiers in Immunology 6.
Crossref
Crossref
Rita Czako & Kanta Subbarao. (2015) Refining the approach to vaccines against influenza A viruses with pandemic potential. Future Virology 10:9, pages 1033-1047.
Crossref
Crossref
Woo Jung Kim, Sang Don Lee, Eun Lee, Kee Namkoong, Kang-Won Choe, Joon Young Song, Hee Jin Cheong, Hye Won Jeong & Jung Yeon Heo. (2015) Incidence of narcolepsy before and after MF59-adjuvanted influenza A(H1N1)pdm09 vaccination in South Korean soldiers. Vaccine 33:38, pages 4868-4872.
Crossref
Crossref
Joanna A. Pulit-Penaloza, Bishu Sapkota, E. Stein Esser, Richard W. Compans, Brian P. Pollack & Ioanna Skountzou. (2015) Modulation of influenza vaccine immune responses using an epidermal growth factor receptor kinase inhibitor. Scientific Reports 5:1.
Crossref
Crossref
Shahla Shahsavandi, Mohammad Majid Ebrahimi, Kaveh Sadeghi & Homayoon Mahravani. (2015) Design of a heterosubtypic epitope-based peptide vaccine fused with hemokinin-1 against influenza viruses. Virologica Sinica 30:3, pages 200-207.
Crossref
Crossref
Katherine Houser & Kanta Subbarao. (2015) Influenza Vaccines: Challenges and Solutions. Cell Host & Microbe 17:3, pages 295-300.
Crossref
Crossref
Giuseppe Del Giudice, Birgit Weinberger & Beatrix Grubeck-Loebenstein. (2015) Vaccines for the Elderly. Gerontology 61:3, pages 203-210.
Crossref
Crossref
Takuo Mizukami, Haruka Momose, Madoka Kuramitsu, Kazuya Takizawa, Kumiko Araki, Keiko Furuhata, Ken J. Ishii, Isao Hamaguchi & Kazunari Yamaguchi. (2014) System Vaccinology for the Evaluation of Influenza Vaccine Safety by Multiplex Gene Detection of Novel Biomarkers in a Preclinical Study and Batch Release Test. PLoS ONE 9:7, pages e101835.
Crossref
Crossref
V.H. Basavaraj, G. Sampath, Nagendra R. Hegde, V. Krishna Mohan & Krishna M. Ella. (2014) Evaluation of safety and immunogenicity of HNVAC, an MDCK-based H1N1 pandemic influenza vaccine, in Phase I single centre and Phase II/III multi-centre, double-blind, randomized, placebo-controlled, parallel assignment studies. Vaccine 32:35, pages 4592-4597.
Crossref
Crossref
Young-Tae LeeKi-Hye KimEun-Ju KoYu-Na LeeMin-Chul KimYoung-Man KwonYinghua TangMin-Kyoung ChoYoun-Jeong LeeSang-Moo Kang. (2014) New vaccines against influenza virus. Clinical and Experimental Vaccine Research 3:1, pages 12.
Crossref
Crossref
M.R. Schleiss. 2014. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.